Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: Implications in endothelial leakiness

Journal of Extracellular Vesicles

Volumn 4, Issue 1, 2015, Pages

  Whitehead, Bradley ^a   Wu, LinPing ^b   Hvam, Michael Lykke ^a   Aslan, Husnu ^a   Dong, Mingdong ^a   DyrskjØt, Lars ^c   Ostenfeld, Marie Stampe ^c   Moghimi, Seyed Moein ^b   Howard, Kenneth Alan ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Complement activation; Endothelial disruption; Extracellular vesicles; Extravasation; Metastatic cell derived exosomes; Nanomechanical properties

Indexed keywords

ANALYTIC METHOD; ATOMIC FORCE MICROSCOPY; CANCER CELL LINE; CELL ADHESION; CELL DISRUPTION; CELL IMMORTALIZATION; CELL ISOLATION; COMPLEMENT ACTIVATION; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALIGNANT NEOPLASM; MONOLAYER CULTURE; NANOPARTICLE TRACKING ANALYSIS; PARTICLE SIZE; QUANTITATIVE NANOMECHANICAL MAPPING ATOMIC FORCE MICROSCOPY; SHORT SURVEY; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84963709613     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v4.29685     Document Type: Short Survey

References (43)

1. van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: a common pathway for a specialized function. J Biochem. 2006;140:13-21
2. Lässer C. Identification and analysis of circulating exosomal microRNA in human body fluids. In: Kosaka N, editor. Circulating microRNAs. Methods in molecular biology. Vol. 1024. Springer Protocols: Humana Press; 2013. p. 109-28
3. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-9
4. Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011;12:1659-68
5. Al-Nedawi K. The Yin-Yang of microvesicles (exosomes) in cancer biology. Front Oncol. 2014;4:172
6. Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470-6
7. Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang WG, Steadman R, et al. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene. 2015;34:290-302
8. Mu W, Rana S, Zöller M. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia. 2013; 15:875-IN4
9. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of b-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190:1079-91
10. OstenfeldMS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, et al. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res. 2014;74:5758-71
11. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70
12. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816-26
13. Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 2011;71:3792-801
14. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18:883-91
15. Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R. Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J Immunol. 2002;169:2102-10
16. Makela K, Helen P, Haapasalo H, Paavonen T. Complement activation in astrocytomas: deposition of C4d and patient outcome. BMC Cancer. 2012;12:565
17. Moghimi SM. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth. J Contr Release. 2014;190:556-62
18. Ostrowski K, Dziedzic-Goclawska A, Strojny P, Grzesik W, Kieler J, Christensen B, et al. Fourier analysis of the cell shape of paired human urothelial cell lines of the same origin but of different grades of transformation. Histochemistry. 1986;84: 323-8
19. Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, et al. Profiling the evolution of human metastatic bladder cancer. Cancer Res. 2004;64:7813-21
20. Gildea JJ, Golden WL, Harding MA, Theodorescu D. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer. Genes Chromosomes Cancer. 2000;27:252-63
21. Jeppesen DK, Hvam ML, Primdahl-Bengtson B, Boysen AT, Whitehead B, Dyrskjøt L, et al. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles. 2014;3:25011, doi: http://dx.doi.org/10.3402/jev.v3.25011
22. Jeppesen DK, Nawrocki A, Jensen SG, Thorsen K, Whitehead B, Howard KA, et al. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors. Proteomics. 2014;14:699-712
23. Zhang S, Aslan H, Besenbacher F, Dong M. Quantitative biomolecular imaging by dynamic nanomechanical mapping. Chem Soc Rev. 2014;43:7412-29
24. Andersen AJ, Robinson JT, Dai H, Hunter AC, Andresen TL, Moghimi SM. Single-walled carbon nanotube surface control of complement recognition and activation. ACS Nano. 2013; 7:1108-19
25. Banda N, Mehta G, Chao Y, Wang G, Inturi S, Fossati-Jimack L, et al. Mechanisms of complement activation by dextrancoated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum. Particle Fibre Toxicol. 2014;11:64
26. Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong DT. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One. 2010;5:e8577
27. Sharma S, Rasool HI, Palanisamy V, Mathisen C, Schmidt M, Wong DT, et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano. 2010;4:1921-6
28. Lekka M, Laidler P, Gil D, Lekki J, Stachura Z, Hrynkiewicz AZ. Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. Eur Biophys J. 1999; 28:312-6
29. van der Vlist EJ, Nolte-'t Hoen ENM, Stoorvogel W, Arkesteijn GJA,WaubenMHM. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat Protocols. 2012; 7:1311-26
30. Reymond N, d'Agua BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013;13:858-70
31. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007;100:158-73
32. Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913, doi: http://dx.doi.org/10.3402/jev.v3.26913
33. Muller WA. Mechanisms of transendothelial migration of leukocytes. Circ Res. 2009;105:223-30
34. Pandit J, Garg M, Jain NK. Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection. J Liposome Res. 2014;24:163-9
35. Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJA, Jimenez CR. Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles. 2013;2:22097, doi: http://dx.doi.org/10.3402/jev.v2.22097
36. Kazakoff P, McGuire T, Hoie E, Cano M, Iversen P. Anin vitro model for endothelial permeability: Assessment of monolayer integrity. In Vitro Cell Dev Biol Anim. 1995;31:846-52
37. Kim Y-N, Koo KH, Sung JY, Yun U-J, Kim H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol. 2012;2012:306879
38. Benito-Martin A, Di Giannatale A, Ceder S, Peinado H. The new deal: a potential role for secreted vesicles in innate immunity and tumor progression. Front Immunol. 2015;6:66
39. Clayton A, Harris CL, Court J, Mason MD, Morgan BP. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol. 2003;33:522-31
40. Moghimi SM, Farhangrazi ZS. Just so stories: the random acts of anti-cancer nanomedicine performance. Nanomedicine. 2014; 10(8):1661-6
41. Kurihara R, Yamaoka K, Sawamukai N, Shimajiri S, Oshita K, Yukawa S, et al. C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflamm Res. 2010;59: 659-66
42. Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Parsa AT. Cancer and the complement cascade. Mol Cancer Res. 2010; 8:1453-65
43. Kerr H, Richards A. Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome. Immunobiology. 2012;217:195-203